Topics

Rgenix, Inc. Company Profile

14:47 EDT 19th September 2019 | BioPortfolio

Rgenix, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancer progression. Using a miRNA based target discovery platform developed by Rgenix’s founders at The Rockefeller University, the company is pursuing several first-in-class drug candidates to treat cancers of high unmet need. The company brings together distinguished scientific founders, a seasoned Board, and a leadership team comprised of experienced drug developers. The company is funded by leading biotechnology investors, including Novo A/S, Sofinnova Partners, and Alexandria Venture Investments. For more information, please visit www.rgenix.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

Rgenix Names Industry Veteran to Chief Medical Officer Role

Robert Wasserman, MD, joins Rgenix with more than 20 years of oncology clinical development experience and prior senior roles in the biopharma industry Wasserman will oversee new Phase 1b/2 trial o...

Rgenix To Present Abstract on RGX-019 at the 2019 AACR Annual Meeting

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today that Isabel Kurth, Ph.D., Vice ...

Rgenix Presents Pre-Clinical Data on RGX-019 at the 2019 AACR Annual Meeting

Pre-clinical data demonstrates first-in-class MERTK selective inhibitor with novel mechanism of action Rgenix has initiated IND-enabling studies of RGX-019 Rge...

Molecular Templates Appoints Roger Waltzman Chief Medical Officer

Roger Waltzman is now chief medical officer of Molecular Templates (NASDAQ: MTEM). Waltzman comes to the Austin, TX, cancer drug developer from Rgenix, where he was chief medical officer. Molecular Te...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Rgenix, Inc.

Rgenix, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancer progre...

More Information about "Rgenix, Inc." on BioPortfolio

We have published hundreds of Rgenix, Inc. news stories on BioPortfolio along with dozens of Rgenix, Inc. Clinical Trials and PubMed Articles about Rgenix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rgenix, Inc. Companies in our database. You can also find out about relevant Rgenix, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record